Global Artificial Pancreas Devices Systems Market Dynamics to Support 12.1% Growth Rate for 2022-2028

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a “closed-loop” system, an “automated insulin delivery” system, or an “autonomous system for glycemic control.”

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.

Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.

North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.

In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals, followed by Clinics.

The global Artificial Pancreas Devices Systems market was valued at US$ 79 million in 2020 and is expected to reach US$ 176.6 million by the end of 2027, growing at a CAGR of 12.1% during 2021-2027.

This report focuses on Artificial Pancreas Devices Systems volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Artificial Pancreas Devices Systems market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Request for a free sample or purchase this report at:

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Threshold Suspended Device Systems
  • Hybrid Closed-loop APDS
  • Other Systems

Segment by Application

  • Hospitals
  • Clinics

By Company

  • Medtronic
  • Bigfoot Biomedical
  • Beta Bionics
  • Admetsys
  • Insulet
  • Tandem Diabetes Care
  • Defymed

Production by Region

  • North America
  • Europe
  • China

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)


Contact Details:

Mr. Shirish Gupta

Sales Manager

The Market Reports | Industry and Market Reports at its Best

Call: +1-631-407-1315 / +91-750-729-1479